Incidence of prostatic intraepithelial neoplasia in TURP specimens with special reference to p63 expression in various lesions of prostate

G Suba; Shaista Choudhary; S Jagadish; Y A Manjunatha

doi:10.53730/ijhs.v6nS8.13291

Authors

Suba G
drsubag@gmail.com
Assistant Professor, Department of Pathology, Dr B R Ambedkar Medical College, K G Halli, Bangalore, Karnataka, India
Shaista Choudhary Associate Professor, Department of Pathology, Dr B R Ambedkar Medical College, K G Halli, Bangalore, Karnataka, India
Jagadish S Professor and HOD, Department of Preventive and Social medicine, Dr B R Ambedkar Medical College, K G Halli, Bangalore, Karnataka, India
Manjunatha Y A Professor and HOD, Department of Pathology, Dr B R Ambedkar Medical College, K G Halli, Bangalore, Karnataka, India

Keywords:

benign prostatic hyperplasia, high grade PIN, adenocarcinoma, basal cell marker

Abstract

Introduction: Prostate cancer is the second common malignancy in men. Prostatic intraepithelial neoplasia (PIN) is the precursor lesion of prostatic carcinoma. Histopathological examination is necessary to diagnose PIN lesions. Objective: The aim of the study is to determine the incidence of Prostatic intraepithelial neoplasia and to analyse the usefulness of basal cell marker p63 expression in various lesions of prostate. Methods: This is a two-year prospective study of 65 transurethral resection specimens of prostate, carried out in the Department of pathology, Dr B R Ambedkar Medical College, Bangalore. mmunohistochemical marker p63 is used and its expression in various lesions was analysed. Results: Out of 65 cases studied, 4 were inflammatory lesions, 52 were benign prostatic hyperplasia (BPH) and 9 were malignant lesions. Low grade PIN was identified in 8(12.3%) cases of BPH. High grade PIN was seen in 9(13.8%) cases and tufting pattern was the commonest. HGPIN was predominantly associated with adenocarcinoma. p63 was expressed in all the benign glands in BPH and HGPIN. Malignant glands were negative for p63 expression.

Downloads

Download data is not yet available.

References

Armah HB, Parwani AV. Atypical adenomatous hyperplasia (adenosis) of the prostate: a case report with review of the literature. Diagn Pathol. 2008 Aug 12;3:34.

Bostwick DG, Amin MB, Dundore P, Marsh W, Schultz DS. Architectural patterns of high-grade prostatic intraepithelial neoplasia. Hum Pathol. 1993 Mar; 24(3):298-310.

Bostwick DG, Qian J. High-grade prostatic intraepithelial neoplasia. Mod Pathol. 2004; 17: 360–379.

Desai SB, Borges AM. The prevalence of high-grade prostatic intraepithelial neoplasia in surgical resection specimens: An Indian Experience. Cancer. 2002; 94: 2350–2352.

Gaudin PB, Sesterhenn IA, Wojno KJ, Mostofi FK, Epstein JI. Incidence and clinical significance of high- grade prostatic intraepithelial neoplasia in TURP specimens. Urology. 1997:49:558-563.

Kruslin B, Tomas D, Cviko A. Periacinar clefting and p63 immunostaining in prostatic intraepithelial neoplasia and prostatic carcinoma. Pathol oncol Res. 2006; 12: 205-209.

Kunju LP, Mehra R, Snyder M, Shah R. Prostate--specific antigen, high molecular--weight cytokeratin (clone 34betaE12), and/ or p63: An optimal immune histochemical panel to distinguish poorly differentiated prostate adenocarcinoma from urothelial carcinoma. Am J Clin Pathol. 2006; 125: 675-81.

Langner C, Ratschek M, Tsybrovskyy O, Schips L, Zigeuner R. p63 immuno reactivity distinguishes upper urinary tract transitional-cell carcinoma and renal-cell carcinoma even in poorly differentiated tumors. J Histochem Cytochem. 2003;51: 1097-9.

Molinie V, Fromont G, Sibony M, Vieillefond A, Vassiliu V, Priollet BC, Herve JM, Lebret T, Baglin AC. Diagnostic utility of a p63/ -methyl-CoA-racemase (p504S) cocktail in atypical foci in the prostate. Mod Pathol. 2004; 17: 1180–1190.

Pacelli A, Bostwick DG. Clinical significance of high grade prostatic intra epithelial neoplasia in transurethral resection specimens. Urology.1997; 50:355–359.

Rawla P. Epidemiology of Prostate Cancer. World J Oncol. 2019 Apr;10(2):63-89.

Rekhi B, Jaswal TS, Arora B. Premalignant lesions of prostate and their association with nodular hyperplasia and carcinoma prostate. Indian J Cancer. 2004; 41: 60-65.

Shah RB, Zhou M, LeBlanc M, Snyder M, Rubin MA. Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer. Am J Surg Pathol. 2002 Sep; 26(9):1161-8.

Signoretti S, Waltregny D, Dilks J, Isaac B, Lin D, Garraway L, Yang A, Montironi R, McKeon F, Loda M. p63 is a prostate basal cell marker and is required for prostate development. Am J Pathol. 2000 Dec; 157: 1769–1775.

Skjorten FJ, Berner A, Harvei S, Robsahm TE, Tretli S. Prostatic intraepithelial neoplasia in surgical resections. Relationship to coexistent adenocarcinoma and atypical adenomatous hyperplasia of the prostate. Cancer. 1997; 79: 1172-1179.

Ud Din N, Qureshi A, Mansoor S. Utility of p63 immunohistochemical stain in differentiating urothelial carcinomas from adenocarcinomas of prostate. Indian J Pathol Microbiol. 2011; 54(1): 59-62.

Yang A, McKeon F. P63 and P73: P53 mimics, menaces and more. Nat Rev Mol Cell Biol. 2000 Dec; 1(3):199-207.

Zynger DL, Yang X. High-grade Prostatic Intraepithelial Neoplasia of the Prostate: The Precursor Lesion of Prostate Cancer. Int J Clin Exp Pathol. 2009 2(4), 327-338.